Closing the Gap
- 1 November 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Cardiology in Review
- Vol. 16 (6) , 305-313
- https://doi.org/10.1097/crd.0b013e31817f9350
Abstract
Hypertension is a common and readily modifiable risk factor for cardiovascular and cerebrovascular disease. Despite extensive clinical trial results and efforts to increase public awareness, it remains inadequately controlled in the general population. Women are particularly vulnerable. Recent data indicate both a growing prevalence of hypertension, particularly in the postmenopausal and African American populations, and significantly lower rates of adequate blood pressure control relative to men. Patient sex has an important influence on the nature of the disease, its management, and outcomes. This review will focus on sex-specific factors that contribute to hypertension in women, and current patterns and efficacy of treatment. In addition, we will highlight evidence-based options for antihypertensive treatment in women.Keywords
This publication has 83 references indexed in Scilit:
- Prehypertension and Cardiovascular Disease Risk in the Women’s Health InitiativeCirculation, 2007
- Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004Hypertension, 2007
- Hypertension and Antihypertensive Therapy in Elderly WomenHypertension, 2006
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and MenJAMA, 2002
- Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trialsThe Lancet, 2000
- Long-Term Absolute Benefit of Lowering Blood Pressure in Hypertensive Patients According to the JNC VI Risk StratificationHypertension, 2000
- Treatment of mild hypertension: A five year controlled drug trialThe American Journal of Medicine, 1980
- Effects of Treatment on Morbidity in HypertensionJAMA, 1967